Medicine
Risk Stratification of Febrile Neutropenia in Outpatient Oncology
Quick fact
The MASCC index, a validated risk-assessment tool, can identify low-risk febrile neutropenia patients with a positive predictive value of over 90% for no serious complications, enabling safe outpatient care for many.
Why this is interesting
When a cancer patient develops a fever after chemotherapy, doctors must make a life-or-death decision in minutes: send them home or admit them to the hospital. How do they know?